EJS ACT-PD: The Edmond J Safra Accelerating Clinical Trials for Parkinson’s trial
EJS ACT-PD is an initiative to transform the way clinical trials are conducted in the UK. As a multi-arm, multi-stage (MAMS) trial platform, EJS ACT-PD will evaluate several potentially disease-modifying treatments in parallel against a shared placebo (dummy drug) group. Contents About the study Led...
ASPro-PD: Ambroxol and Parkinson’s
ASPro-PD, or Ambroxol to Slow Progression in Parkinson’s, is a phase 3 clinical trial looking to assess whether ambroxol, a cough medicine, can slow or stop the progression of Parkinson’s motor symptoms. Contents About the study Led by Professor Anthony Schapira at University College London...